Andrew R. Robbins - President and CEO, Director at Cogent Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
COGT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew R. Robbins since 7/7/2023

Holdings reported by Andrew R. Robbins for Cogent Biosciences, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 1,100,000 $7.9 M $7.19 Jan 23, 2024 Direct Common Stock

Transactions reported by Andrew R. Robbins for Cogent Biosciences, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership